The average one-year price target for CME Group Inc. - Depositary Receipt (BOVESPA:CHME34) has been revised to R$83.80 / ...
StockStory.org on MSN
CME Q3 deep dive: diversified volume growth and product innovation underpin results
Financial derivatives exchange CME Group (NASDAQ:CME) announced in Q3 2026, with sales up 13% year on year to $1.74 billion.
For my 4th coverage of CME Group Inc., I'm actually upgrading it to a Strong Buy, even more confident than today's consensus. A key growth factor could be driven by CME's market data ...
CME Group Inc. (NASDAQ:CME) and Intercontinental Exchange, Inc. (NYSE:ICE) are both dominant pieces of financial-market ...
CME CEO Terry Duffy calls crypto perps swaps while CME sues the CFTC over their approval. Here is how the regulator answers.
CME Group remains a Buy, driven by robust volumes, an expanding fixed-income ecosystem, and product innovation, despite a full valuation. CME's Q2 2026 saw record revenues, strong margins near 70%, ...
Late on Friday, October 2, CME Group (NASDAQ:CME | CME Price Prediction) put out a short release with a direct title: “CME Group Suspends Plans to Launch 24/7 10-Barrel Crude Oil Contract.” The ...
Sunil Cutinho, Chief Information Officer at CME Group Inc. Transaction details: Sale of 5,000 shares of Class A Common Stock ...
CME commands a 2.5x revenue advantage, but Morningstar's unbroken eight-quarter growth streak tells a different story about ...
Increased volatility, supportive U.S. economic policies under President Donald Trump, higher acceptance of digital assets, continued efforts of the exchange players to go beyond only trading activity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results